We analyzed the gap between the GXP data integrity guidance issued by the Medicines & Healthcare products Regulatory Agency (MHRA) and the current state of GLP data management in Japan. As a result, the gaps that had a strong impact were related to governance systems, blank format management, and computerized system management. Among them, the gap for blank format management and computerized system management was thought to require significant costs and tasks to fully address the gap.